WU
38
6
ADM
44
8
NI
75
3
CAG
41
2
CNP
52
3
MCHP
60
-5
DTE
58
2
SYF
83
2
MPC
50
-2
NAVI
41
-5
ALLE
60
7
IPG
43
3
UNM
62
3
KMI
73
2
AFL
46
2
ADT
86
4
MDLZ
38
-6
ECL
47
2
LUV
65
2
AAPL
46
-2
WU
38
6
ADM
44
8
NI
75
3
CAG
41
2
CNP
52
3
MCHP
60
-5
DTE
58
2
SYF
83
2
MPC
50
-2
NAVI
41
-5
ALLE
60
7
IPG
43
3
UNM
62
3
KMI
73
2
AFL
46
2
ADT
86
4
MDLZ
38
-6
ECL
47
2
LUV
65
2
AAPL
46
-2
Financhill
Back

Zealand Pharma AS 10K Form

Sell
39

ZLDPF
Zealand Pharma AS

Last Price:
$62.20
Seasonality Move:
18.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZLDPF News And Ratings

See the #1 stock for the next 7 days that we like better than ZLDPF

ZLDPF Financial Statistics

Sales & Book Value

Annual Sales: $9.1M
Cash Flow: $-71.8M
Price / Cash Flow: 0
Annual Sales: $17.05
Price / Book: 3.55

Profitability

EPS (TTM): -2.48800
Net Income (TTM): $-170.4M
Gross Margin: $8M
Return on Equity: -15.5%
Return on Assets: -14.04%

Zealand Pharma AS Earnings Forecast

Key Zealand Pharma AS Financial Ratios

  • The Gross Profit Margin over the past 18 years for ZLDPF is 87.44%.
  • The Selling, General & Administrative Expenses for ZLDPF have been equal to 365.60% of Gross Profit Margin.
  • The Research & Development expenses have been 1,467.30% of Revenue.
  • The Net Earning history of ZLDPF is -1,720.87% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 7 years.

Zealand Pharma AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ZLDPF
Website: zealandpharma.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 25.1
Quick Ratio: 24.39

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ZLDPF Technical Analysis vs Fundamental Analysis

Sell
39
Zealand Pharma AS (ZLDPF) is a Sell

Is Zealand Pharma AS a Buy or a Sell?